Eisai's Halaven stumbles at NICE efficacy hurdle
19 July 2011
Francesca Bruce
Please Login to read the full article.
19 July 2011
Francesca Bruce
Please Login to read the full article.
RELATED CONTENT
NEWS
- Eisai mulls NICE appeal after another no for Halaven
- EMA's trial design hinders Eisai's Halaven reimbursement in Germany
- Halaven price in Italy likely to be higher than UK price rejected by NICE
- Scotland says no to Halaven for breast cancer and yes to Levitra for erectile dysfunction
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
